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SusG is an a-amylase and part of a large protein
complex on the outer surface of the bacterial cell
and plays a major role in carbohydrate acquisition
by the animal gut microbiota. Presented here, the
atomic structure of SusG has an unusual extended,
bilobed structure composed of amylase at one end
and an unprecedented internal carbohydrate-bind-
ing motif at the other. Structural studies further
demonstrate that the carbohydrate-binding motif
binds maltooligosaccharide distal to, and on the
opposite side of, the amylase catalytic site. SusG
has an additional starch-binding site on the amylase
domain immediately adjacent to the active cleft.
Mutagenesis analysis demonstrates that these two
additional starch-binding sites appear to play a role
in catabolism of insoluble starch. However, elimina-
tion of these sites has only a limited effect, suggest-
ing that they may have a more important role in
product exchange with other Sus components.INTRODUCTION
The trillions of microbes inhabiting the human distal gut have
a profound effect on human health. The indigenous microbial
flora (microbiota), which outnumbers human cells by several
orders of magnitude (Hooper and Gordon, 2001), shields the
intestinal tract from pathogen colonization and promotes matu-
ration and proliferation of gut cells (Mazmanian et al., 2005).
Systemically, the microbiota stimulates the development of the
immune system andmay offer protection from allergic inflamma-
tory responses such as asthma (Noverr and Huffnagle, 2004;
Penders et al., 2007; Umetsu et al., 2002). The microbiota func-
tions as a metabolic organ with enzymatic properties that
enhance or supercede our own, such as the ability to degrade
resistant dietary or host-derived glycans that transit the distal
gut (Bjursell et al., 2006; Martens et al., 2008; Sonnenburg
et al., 2005; Xu et al., 2003). Through this symbiotic activity,
the microbiota also supplies nutrients to the animal host. For
example, short-chain fatty acids provided from the bacterial
fermentation of glycans can account for as much as 10% of200 Structure 18, 200–215, February 10, 2010 ª2010 Elsevier Ltd Allthe daily caloric intake for individuals on a Western-style, carbo-
hydrate-rich, diet (Backhed et al., 2005). Thus, a thorough under-
standing of the metabolic capabilities of the microbiota will
provide significant insight into our own biochemical makeup
and may lead to better strategies for manipulating human nutri-
tion and the treatment of colon-related diseases.
Colonic Bacteroides species account for nearly 45% of all
bacterial species in the human gut microbiota (Ley et al., 2006)
and harvest a vast array of dietary and host-derived glycans
via outermembrane protein complexes that capture, degrade,
and import polysaccharides (Bjursell et al., 2006; Martens
et al., 2008; Sonnenburg et al., 2005; Xu et al., 2003). The genes
encoding these proteins are clustered together in similarly
patterned polysaccharide utilization loci (PULs) and include
one or more glycolytic enzymes as well as homologs of the
proteins SusC and SusD involved in glycan recognition and
import. The starch utilization system (Sus) of the prominent
human gut symbiont Bacteroides thetaiotaomicron was the first
such PUL to be described (Anderson and Salyers, 1989a,
1989b). The Sus system of B. thetaiotaomicron is composed of
eight genes, susRABCDEFG (Figure 1). SusR is a transcriptional
regulator that turns on the expression of the other seven sus
genes in response to maltooligosaccharides, amylose, amylo-
pectin, and pullulan (D’Elia and Salyers, 1996b). SusCDEFG
are localized to the cell surface and likely form a complex that
processes and imports starch (Anderson and Salyers, 1989b;
Cho and Salyers, 2001; Shipman et al., 1999, 2000; Tancula
et al., 1992). SusDEFG are lipoproteins tethered to the outer
surface of the cell, whereas SusC is predicted to be a TonB-
dependent, b barrel porin. Unlike other TonB-dependent porins
characterized to date, SusC cannot bind ligand alone and
requires the starch-binding protein SusD for starch import (Cho
and Salyers, 2001). We recently determined the atomic structure
of SusD and demonstrated that its binding to starch molecules is
driven by recognition of the overall three-dimensional shape of
the ligand rather than by individual moieties (Koropatkin et al.,
2008). Therefore, SusD likely plays a critical role in targeting poly-
meric starch to the Sus complex and may facilitate movement of
linear oligosaccharides to the SusC porin. SusA and SusB are
a periplasmic neopullulanase and an a-glucosidase, respec-
tively, that presumably break down smaller maltooligosacchar-
ides (D’Elia and Salyers, 1996a; Kitamura et al., 2008).
SusG is the a-amylase expressed concomitantly with Sus-
CDEF on the outer surface of the cell and is absolutely required
for growth on starch. a-amylases are members of glycosiderights reserved
Figure 1. The Starch Utilization System of Bacteroides thetaiotao-
micron
Cartoon representation of Sus operon protein products (Cho and Salyers,
2001; D’Elia and Salyers, 1996a; Shipman et al., 1999, 2000). The stoichiom-
etry of the various proteins in the Sus complex is not known. SusD is
a starch-binding protein of known structure (Koropatkin et al., 2008).
Structure
Structure of a Bacteroides a-Amylase, SusGhydrolase family 13 (GH13), one of largest families of carbohy-
drate-active enzymes (http://afmb.cnrs-mrs.fr/cazy/index.html).
Members of this family include amylases, a-glucosidases, (neo)-
pullulanases, and cyclodextrin glucosyltransferases, many of
which have been extensively studied structurally and biochemi-
cally. These enzymes share a highly conserved (a/b)8 barrel core
structure and an enzymatic mechanism featuring a double-
displacement, general acid/base catalytic scheme that retains
stereochemistry at the anomeric carbon.
SusG is essential for the growth of B. thetaiotaomicron on
starch, despite the presence of four other (non-Sus-associated)
predicted amylases in its genome. In previous work, susG dele-
tion mutants could still bind starch at the cell surface, but could
not grow on amylopectin or pullulan (Shipman et al., 1999).
Although the Sus genes are not required for growth on maltose
or maltotriose, a DsusABCDEFG mutant complemented with
SusG cannot grow on amylose or amylopectin even though
such complementation restored extracellular starch-degrading
activity (Shipman et al., 1999). Therefore, SusG may have
evolved to work as part of a carbohydrate-processing/import
complex rather than just as an outer-membrane amylase. Initial
investigation of the SusG amino acid sequence revealed an
internal stretch of amino acids (residues 190–360) with no iden-
tifiable sequence homology to the many well-characterized
GH13 enzymes or carbohydrate-binding modules (CBMs) (Alt-
schul et al., 1997).
Since the discovery of the Sus complex inB. thetaiotaomicron,
87 similar Sus-like PULs have been identified in this species,Structure 18, 200comprising 18% of the genome. Whole-genome transcriptional
profiling suggests that each of the Sus-like PULs targets different
glycans with only minor redundancy (Martens et al., 2008; Son-
nenburg et al., 2005). An additional 269 Sus-like PULs have
been identified in four other human gut isolates and many others
have been identified in nongut environmental Bacteroidetes,
suggesting that the Sus-like complexes represent a paradigm
for glycan uptake in these bacteria (Xu et al., 2007). However,
despite the predominance of these complexes in Bacteroidetes,
little is understood about the individual protein components of
any particular complex, or how these proteins work together to
import glycans. To that end, the structure and biochemical prop-
erties of another Sus component, SusG, are presented here. The
protein has an extended bilobed architecture with a novel CBM
at one end and the amylase at the other. From structural and
biochemical analysis, it seems likely that this unusual domain
organization is designed not only for digestion of large, insoluble
starch molecules but also for the retention of oligosaccharides
by the Sus complex for passage into the cell. Therefore, it seems
possible that substrate specificity in these nutrient acquisition
systems is not only governed by the details of carbohydrate-
protein interactions but also in the manner that these protein
modules are assembled.
RESULTS
SusG Apo Structure
The SeMet-substituted structure of apo SusG (residues 24–692)
was determined using single-wavelength anomalous dispersion
(SAD) to 2.2 A˚ (Rwork = 19.6%, Rfree = 23.0%). The final model
contained two molecules of SusG (residues 43–692 and 44–
692 were observed) in the asymmetric unit in addition to a
number of small ligands: twoMg2+, two Ca2+, 13 ethylene glycol,
5 acetate, 1 PEG, and 467 water molecules. Native PAGE anal-
ysis suggested that SusG is a monomer in solution (data not
shown).
SusG is composed of A, B, and C domains that share struc-
tural features with other amylases (Figure 2A). The A domain
(residues 43–152 and 364–607) has an eight-stranded a/b barrel
that contains the catalytic site, with the B domain (residues 153–
215 and 336–363) inserted between b3 and a3 of the A domain.
The B domain consists of two two-stranded antiparallel b sheets,
two a helices, and three 310 helices that pack against the
A domain and contribute to the size and accessibility of the
active site. The C domain (residues 608–692) folds into an
eight-stranded b sandwich, and is a common feature of many
GH13 family enzymes. SusG displays an unusual elongated
shape, 120 A˚ in length, due to the insertion of a CBM (residues
216–335) that protrudes from the B domain. This CBM, hereafter
referred to as CBM58, displays a b sandwich fold with immuno-
globulin-like topology, composed of one five-stranded antipar-
allel b sheet opposing a four-stranded antiparallel b sheet.
CBM58 makes no direct contact with the ABC domains, and is
linked to the core amylase fold by two short linkers that span
the 12 A˚ between the B domain and the CBM58. The linker
sequences, SDETAA (residues 212–217) and DSQQI (residues
334–338), are not inherently flexible, and the B factors of these
atoms are consistent with neighboring protein atoms. The linker
strands do not directly interact with each other, the core–215, February 10, 2010 ª2010 Elsevier Ltd All rights reserved 201
Figure 2. The Structure of SusG
(A) Ribbon diagram of SusG, colored by domain:
the A domain (residues 43–152 and 364–607) is
in blue, the B-domain (residues 153–215 and
336363) is in red, the starch-binding domain
(CBM58, residues 216–335) is in pink, and the
C-domain (residues 608–692) is in yellow. The
metal ions are displayed as orange spheres, and
likely ethylene glycol molecules are in light green.
The locations of bound maltoheptaose molecules
are represented by mauve, green, and gray
spheres to the active site, the secondary starch-
binding site, and CBM58, respectively.
(B) Overlay of SusG (blue) with theHalothermothrix
orenii a-amylase (PDB ID code 1WZA; yellow), and
the Thermotoga maritima 4-a-glucanotransferase
(PDB ID code 1LWJ). The arrow highlights a loop
that occludes the active site of the a-amylase
and glucanotransferase, missing in SusG, that
may account for differences in substrate speci-
ficity between these homologs.
Structure
Structure of a Bacteroides a-Amylase, SusGdomains, or the CBM58, but have a few potential water-medi-
ated hydrogen bonds with each other. When residues 365–692
of chains A and B are superimposed (root-mean-square devia-
tion [rmsd] 0.3 A˚) there is some displacement of the CBM58s,
with a 3.3 A˚ deviation in the Ca atoms at the distal end. The loca-
tion of the CBM58, both internal to the amino acid sequence and202 Structure 18, 200–215, February 10, 2010 ª2010 Elsevier Ltd All rights reservedremote from the core domains, has not
been observed in any other GH13 struc-
ture, although some bacterial amylopullu-
lanases have predicted starch-binding
CBM20 domains internal to the polypep-
tide sequence (Machovic et al., 2005).
The apo SusG structure has two metal
ions, modeled as Ca2+ and Mg2+ based
upon the distance and geometry of the
coordinating atoms (Figure 2A). Both of
these ions bind in locations typically
occupied by Ca2+ in other amylase struc-
tures, and contribute to structural integ-
rity (Abe et al., 2004; Hondoh et al.,
2003; Robert et al., 2005; Roujeinikova
et al., 2002; Sivakumar et al., 2006). The
Ca2+ ion is located between the A and B
domains, 12 A˚ from the catalytic site,
and is coordinated by two water mole-
cules, the main-chain O of H392 and
I393, and the side chains of D352 and
N153, with an average coordinating
distance of 2.4 A˚. The Mg2+ ion is coor-
dinated by one water molecule, the main-
chain O of Y79, and the side chains of
D73, D75, D77, and D81, with average
distances of 2.0–2.3 A˚. These residues
lie within a surface loop that connects
b1 and a1 in the catalytic A domain,
remote from the active site.
Excluding CBM58, SusG shares the
most sequence and structural similaritywith Halothermothrix orenii a-amylase A (Protein Data Bank
[PDB] ID code 1WZA; rmsd of 1.8 A˚ for 447 Ca atoms with
a 34% sequence identity) (Sivakumar et al., 2006) and Thermo-
toga maritima 4-a-glucanotransferase (PDB ID code 1LWJ;
rmsd of 2.0 A˚ for 426 Ca atoms and a 28% sequence identity)
(Roujeinikova et al., 2002), as determined by the Dali server
Figure 3. Maltooligosaccharide Bound to
the Novel Carbohydrate-Binding Domain,
CBM58, of SusG
(A) Electron density from an omit map at the carbo-
hydrate binding to the CBM58 domain. The elec-
tron density is contoured at 3s.
(B) Stereo view of maltopentaose bound at the
starch-binding domain with the potential hydrogen
bonds denoted by dashed lines. Glucose residues
in the oligosaccharide are numbered from the
nonreducing end. For clarity, the view in (A) is look-
ing into the carbohydrate-binding region, whereas
in (B) the view is from the side.
(C) Alignment of CBM58 (from SusD), CBM26
(from the amylase of Bacillus halodurans; PDB ID
code 2C3H), and CBM41 (from the pullulanase of
Thermotoga maritima, PulA; PDB ID code 2J73)
in blue, red, and green, respectively. The bound
oligosaccharides are shown as stick figures in
colors corresponding to the ribbon diagrams.
Structure
Structure of a Bacteroides a-Amylase, SusG(Holm and Sander, 1995). In both instances, the most divergent
part of the structures is within the B domain, adjacent to the
active site (Figure 2B). The B domain loop created by residues
163–175 inH. orenii amylase A and 123–136 in T.maritima gluca-
notransferase lines one side of the entrance to the active site,
partially restricting substrate access. In contrast, residues 183–
207 in the B domain of SusG form a helix-turn-310 helix that
points away from the catalytic site, creating a much wider cleft
for substrates to enter, and may contribute to substrate speci-
ficity as discussed below.Structure 18, 200–215, February 10, 2010Based upon amino acid sequence, the
domain composed of residues 216–335
represents a new starch-binding CBM
family, designated CBM58 by the Carbo-
hydrate-Active EnZymesdatabase (CAZy;
http://www.cazy.org). The topology of
the b strands is quite different compared
to other CBM families, with one five-
stranded b sheet composed of b5-b6-
b1-b2-b10 opposing a four-stranded
b sheet composed of b4-b3-b7-b8, and
a 14 residue elongated loop that con-
nects b2 and b3. Two additional parallel
b strands, b9 and b11, form a small
b sheet. The sheet b5-b6-b1-b2-b10 is
flat whereas the opposite face features
three protruding loops, residues 262–
264 connecting b3 and b4, residues
286–288 connecting b6 and b7, and resi-
dues 295–301 connecting b7 and b8, that
create an oligosaccharide-binding de-
pression over the sheet. Within this
binding pocket, Y260, W287, and W299
form the starch-binding site. This new
CBM shares the most structural similarity
with the starch-binding proteins CBM26
of Bacillus halodurans maltohexaose-
forming amylase (PDB ID code 2C3H)and CBM41 of T. maritima pullulanase PulA (PDB ID code 2J73)
(Boraston et al., 2006; Lammerts van Bueren and Boraston,
2007). Despite a different pattern of connectivity, the b strands
of CBM58 are positioned similarly to CBM26 (PDB ID code
2C3H; rmsd of 1.39 A˚ for 45 Ca, 18% sequence identity) and
CBM41 (PDB ID code 2J73; rmsd of 1.3 A˚ for 43 Ca, 15%
sequence identity), with the starch-binding sites on the same
face of the b sandwich (Figure 3C). These structural alignments
reveal a conserved mode of starch binding, with a Trp-Trp/Tyr
pair that creates a shallow pocket for binding helical a1,4-glucan.ª2010 Elsevier Ltd All rights reserved 203
Structure
Structure of a Bacteroides a-Amylase, SusGSusG-D498N/Maltoheptaose Structure
Catalytic residues of SusG were initially identified from
a sequence alignment with the H. orenii AmyA and SusG was in-
activated with a D498N mutation, as confirmed using PNP-mal-
tohexaose and amylose as substrates. This D498N mutant was
crystallized in the presence of maltoheptaose and the structure
was determined to a resolution of 2.3 A˚ (Rcryst = 18.6%,
Rfree = 21.7%). These crystals were isomorphous to the apo
crystals despite the fact that 100 mM LiSO4 and 0.5 mM CaCl2
replaced the magnesium acetate. Under these conditions,
Ca2+ replaced the Mg2+ ion observed in the apo structure, in-
ferred by the increase in the average coordination distance to
2.3–2.6 A˚. In this mutant form of SusG, maltooligosaccharide
was observed at three sites: the catalytic cleft, CBM58, and
a surface starch-binding site adjacent to the active site (Fig-
ure 2A). The structure of this D498N mutant can be superim-
posed onto the wild-type (WT) SusG with an rmsd of <0.45 A˚,
and no conformational changes were observed as a result of
maltooligosaccharide binding. In the following sections, glucose
residues are numbered from the nonreducing end of the
maltoheptaose. At both the surface site and the CBM58, the f
(O5-C1-O40-C40), c (C1-O40-C40-C50) angles of maltooligosac-
charide approximate those typically found in double-helical
amylose (f = 91.8, c = 153.2; f = 85.7, c = 145.3;
f = 91.8, c = 151.3) (Imberty et al., 1988).
The CBM58-Binding Site
Five glucose residues of maltoheptaose are well ordered at the
CBM58, cradled by the loops that form the binding pocket on
one face of the b sandwich (Figure 3). Glc3 andGlc4 of the bound
maltoheptaose stack against two tryptophans in the binding
pocket: W299 and W287. Adding to the hydrophobic character
of this area, L290 lies between these two tryptophans. The
side chain of E263 is located 3.6 and 2.8 A˚ from the O-6 of
Glc1 and Glc2, respectively. The O-2 and O-3 of Glc3 are
hydrogen bonded with the side-chain Od1 and Nd2 of N330, at
2.6 and 3.2 A˚, respectively. Similarly, the Nz of K304 is positioned
3.0 A˚ from the O-3 and 2.8 A˚ from the O-2 of Glc4. The O-6 of
Glc3 points toward the phenolic oxygen of Y260 (2.7 A˚). At the
reducing end of the maltoheptaose, Glc5 does not form any
stacking or hydrogen-bonding interactions with the protein.
The pattern of starch binding at the CBM58, characterized by
an arc of hydrophobic residues with additional hydrogen
bonding to the 20 and 30 hydroxyl groups of adjacent glucose
residues, is a generally conserved feature of many starch-
binding CBMs (Boraston et al., 2006). In addition, this binding
pattern is observed in SusD (Koropatkin et al., 2008) and in barley
and pancreatic a-amylases that bind raw starch on the surface of
the catalytic domain (Qian et al., 1995; Robert et al., 2005).
The Active Site
Maltoheptaose assumes a curved shape similar to b-cyclodex-
trin in the active site with f,c angles of 46 and 150 between
the 1 and +1 subsite residues Glc4 and Glc5. In general, the
glucose residues in the active site are positioned by hydrogen-
bonding interactions through their O-2 and O-3 atoms with few
hydrophobic stacking interactions (Figure 4). Themost extensive
protein-glycan interactions are observed with Glc3, Glc4, and
Glc5, corresponding to subsites 2,1, and 1. The architecture204 Structure 18, 200–215, February 10, 2010 ª2010 Elsevier Ltd Allof the active site is similar to many GH13 enzymes, and this
homology infers that D388, E431, and D498 have key roles in
a general acid-base double-displacement mechanism (Qian
et al., 2001). At the nonreducing end, Glc1 makes potential
hydrogen bonds between O-2 and the side chains of D545
(2.7 A˚) and K541 (3.3 A˚), and O-3 with K541 (3.4 A˚). This residue
is disordered in the other copy of SusG in the crystallographic
asymmetric unit. The O-3 of Glc2 hydrogen bonds with the back-
bone N and the side chain of D545. Glc3 stacks against the
hydrophobic face of H112, with O-2 forming likely hydrogen
bonds with side-chain N atoms of R549, and its O-3 atom form-
ing likely hydrogen bonds with the side chains of D545 andR549.
The phenyl side chains of F345 and F350 lend additional
hydrophobic character along the O-5, C-6 face of Glc3 and
Glc4. Glc4 stacks against the phenolic side chain of Y114, and
is positioned by an extensive network of hydrogen bonds. O-2
of Glc4 is proximal to the side-chain atoms of N498, R386, and
E431, whereas the O-3 atom interacts with the side chains
H497 and N498. O-6 of Glc4 interacts with the N32 of H154,
and O-5 with the side chain of D388. D388 is positioned 3 A˚
from the C1 of Glc4, supporting its role as the nucleophilic
base that forms the b-glucosyl enzyme intermediate. E431 inter-
acts with O-4 of Glc5, likely supplying a proton to the leaving
a-glucan chain and then activating a water molecule for hydro-
lysis of the enzyme intermediate. D498, mutated to Asn in this
structure, plays a critical role in catalysis, perhaps bymaintaining
the pKa of the general acid and/or by stabilizing the positive
charge of the transition state, believed to have carbonium ion
character (McCarter and Withers, 1994, 1996; Qian et al.,
2001; Strokopytov et al., 1995; Uitdehaag et al., 1999). The
portion of maltoheptaose representing the leaving a-glucan
chain, Glc5–Glc7, has fewer contacts with the protein. The O-2
andO-3 atoms of Glc5 form hydrogen bondswith the side chains
of H392 and E431. The O-2 of Glc6 interacts with the backbone
O of L433, whereas the O-3 interacts with the Nz of K391. Glc7 at
the reducing end of maltoheptaose is 4 A˚ from the aromatic
face of Y456 but is not optimally positioned for aromatic stacking
interactions.
The Surface Starch-Binding Site
Directly adjacent to the reducing end of the active site maltohep-
taose is an additional surface starch-binding site (Figure 5). The
O1 atom of Glc7 from the oligosaccharide bound to the active
site is 4.5 A˚ from the O-2 atom of Glc5 of the surface-site-bound
ligand, resulting in close proximity of the reducing ends of each
maltooligosaccharide. This orientation makes it unlikely that a
continuous segment of a-glucan spans both the active site and
the surface site during catalysis. In both subunits of SusG, six
of the seven glucose residues of maltoheptaose could be
modeled at the surface site. As described for CBM58, an arc
of aromatic amino acids creates a hydrophobic surface for
binding a-glucan, with additional hydrogen-bonding interactions
with the O-2 and O-3 atoms provided by polar side chains. Glc4
and Glc3 stack against W460 and Y469, while T466 and several
water molecules occupy the small space between W460 and
Y469. This is in contrast to CBM58, in which L290 and Y260
lend additional hydrophobic character to the binding cleft
between the two tryptophans. The O-2 and O-3 atoms of Glc3
interact with the side chain of D473, whereas O-2 and O-3 ofrights reserved
Figure 4. Maltooligosaccharide Bound to
the Active Site of SusG
(A) Electron density from an omit map at the SusG
active site of the SusG-D498N mutant cocrystal-
lized with maltoheptaose. The electron density is
contoured at 3s and the stick model of the bound
oligosaccharide is colored according to atom
type.
(B) Stereo view of oligosaccharide bound at the
starch-binding domain, with the potential
hydrogen bonds denoted by dashed lines.
(C) Schematic of enzyme-substrate interactions in
the active site. Glucose residues in the oligosac-
charide are numbered from the nonreducing end,
and enzyme subsites 4 through +3 are labeled
for clarity.
Structure
Structure of a Bacteroides a-Amylase, SusG
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Figure 5. Maltoheptaose Bound to the Secondary Oligosaccharide-Binding Site Adjacent to the Active Site
(A) Electron density from an omit map of the SusG-maltoheptaose complex at the secondary carbohydrate-binding site immediately adjacent to the active site.
Note that the glucose ring in the upper left corner is from the oligosaccharide bound to the active site. The electron density is contoured at 3s.
(B) Stereoview of oligosaccharide bound at this secondary binding site, with the potential hydrogen bonds denoted by dashed lines. Glucose residues in the
oligosaccharide are numbered from the nonreducing end. For clarity, the view in (A) is looking into the carbohydrate-binding region, whereas in (B) the view
is from the side.
Structure
Structure of a Bacteroides a-Amylase, SusGGlc4 bind to the guanidinium group of R457. The O-2 atom of
Glc2 hydrogen bonds with the Nz of K472, and the reducing
end O1 of Glc6 binds to the side chain of D437. The close prox-
imity of this additional binding site and the catalytic site may
restrict the length of a-glucans that can bind to either site during
the catalytic cycle. The architectural similarity of the active site of
SusG compared with other a-amylases, including the orientation
of maltoheptaose, suggests that the a-glucan chain is cleaved at
the reducing end, making the surface site proximal to the leaving
a-glucan chain.
Acarbose Binding to SusG
Acarbose is used to treat type 2 diabetes and, in some countries,
prediabetes, by blocking starch degradation via inhibition of
a-amylase (Sharma and Garber, 2009). To further detail the
active site of SusG, the structure of selenomethionine-
substituted WT SusG complexed with the amylase inhibitor,
acarbose, was determined to a resolution of 2.5 A˚ (Rcryst =
20.2%, Rfree = 24.9%). Acarbose is a pseudotetrasaccharide
composed of the disaccharide acarviosine with an a-1,4 linkage
to maltose (Figure 6A). The nonhydrolyzable acarviosine moiety206 Structure 18, 200–215, February 10, 2010 ª2010 Elsevier Ltd Allcontains an unsaturated cyclitol ring N-linked to 4,6-dideoxy-
4-amino-D-glucose, and is thought to act as a transition-state
analog for the amylase reaction. Whereas intact acarbose was
observed at both the CBM- and surface-binding sites, a b-gluco-
syl enzyme intermediate was captured in the active site (Figure 6)
with D388 covalently linked to the pseudotrisaccharide acarvio-
sine-glucose, with maltose occupying subsites +1/+2. To our
knowledge, this is the first GH13 enzyme structure bound to
a covalent intermediate that is not derived by the use of a fluori-
nated substrate or a site-directed mutant. However, this has
been previously observed with acarbose in the case of Thermus
thermophilus amylomaltase, a related enzyme belonging to
glycoside hydrolase family 77 (Barends et al., 2007).
It is not clear how the intermediate was trapped in the active
site. Acarbose was added to the protein prior to crystallization
and occasionally stored for more than 2 weeks prior to crystalli-
zation, whichmay have allowed for significant degradation of the
pseudotetrasaccharide. Crystals were grown over a period of
2 weeks at room temperature, prepared for data collection
by transferring to increasing concentrations of cryoprotectant
containing fresh acarbose, and flash-frozen within 1 min of therights reserved
Figure 6. Enzyme-Linked Intermediate of
the SusG Reaction with Acarbose
(A) Chemical structure of acarbose, a pseudotetra-
saccharide inhibitor of a-amylase and a-glucosi-
dase.
(B) Electron density of acarviosine-glucose cova-
lently linked to the active site, D388, and maltose
from the corresponding omitmap contoured at 3s.
(C) Overlay of the active site from the WT-SusG
structure with acarbose (solid sticks) with that
of the SusG-D498N structure complexed with
maltoheptaose (transparent model).
Structure
Structure of a Bacteroides a-Amylase, SusGfinal transfer. Slow release of the pseudotrisaccharide, com-
bined with the displacement of water by cryoprotectant, may
have trapped the covalent intermediate. The presence of
maltose, rather than glucose, in subsites +1/+2 is surprising.
Neither the acarbose stock solution nor the SusG and acarbose
reaction have appreciable quantities of maltose as assessed by
thin-layer chromatography (TLC). It is possible that SusG cleaves
maltose, rather than glucose, from the reducing end of acarbose
as aminor reaction, and that maltose observed in this structure is
simply the result of such a previous catalytic event. Many GH13
enzymes perform transglycosylation and subsequent cleavage
of acarbose that can result in the generation and breakdown
of a pentasaccharide that would yield acarviosine-glucose and
maltose (e.g., human pancreatic a-amylase; Li et al., 2005).
However, if SusGperforms transglycosylation it must be an infre-Structure 18, 200–215, February 10, 2010quent event, because the products of
such a side reaction were not detected
by TLC (see Figure 9).
Despite slight perturbations, an iden-
tical pattern of hydrogen bonding is
observed in the active sites of the WT
SusG complexed with acarbose and the
SusG-D498Nmutant bound tomaltohep-
taose. The nucleophilic base D388 shifts
slightly upon attack on acarbose C-1,
resulting in the inversion of stereochem-
istry at the anomeric carbon and the
b-glucosyl intermediate. The side chain
of E431 is positioned 3.1 A˚ from the
nonreducing O-4 end of the leaving
maltose group, whereas this distance is
3.4 A˚ in the maltoheptaose-bound struc-
ture. Similarly, the side chain of D498
and the anomeric C-1 of the pseudotri-
saccharide are both 3.1 A˚ from the
nonreducing O-4 of maltose. Both the
bound glucosyl-enzyme intermediate
and maltose molecules are well ordered,
suggesting that nearly all of the active
sites are occupied by these ligands in
this configuration.
At the CBM, acarbose binds in a similar
manner as the oligosaccharide in the
SusG-D498N structure and occupies
the same subsites as Glc2–Glc5 ofmalto-pentaose (Figure 7). By virtue of the unsaturated bond in acar-
bose, the O-6 atom of the cyclitol moiety is slightly shifted, and
the side chain of E263 is directed away from the binding site.
At the surface site, acarbose is bound in the same subsites
occupied by Glc2–Glc5 of maltohexaose in the SusG-D498N
structure (Figure 8). Glucose at the reducing end of acarbose is
shifted less than 1 A˚ in the direction of the active site compared
to Glc5 of maltopentaose.
Enzymatic Activity
A qualitative analysis of the enzymatic and starch-binding prop-
erties of SusG was performed to better understand the possible
roles of these various carbohydrate-binding domains. Polysac-
charide affinity gel electrophoresis indicated that SusG is flexible
in its carbohydrate selectivity because it binds to and degradesª2010 Elsevier Ltd All rights reserved 207
Figure 7. Acarbose Bound to the CBM58 Domain
(A) The electron density of acarbose bound to the CBM58 domain. For this figure, the omit map was contoured at 3s.
(B) Comparison of acarbose binding (solid sticks) with the SusG-D498N structure cocrystallized with maltoheptaose (transparent model).
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Structure of a Bacteroides a-Amylase, SusGpullulan, amylopectin, and amylose. To assess the relative
substrate preference of SusG, the amount of reducing sugar
liberated over time was assessed using soluble starch (potato),
amylopectin (maize), pullulan, a-cyclodextrin, and b-cyclodex-
trin as substrates (Table 1). From these data, it is clear that
SusG prefers soluble starch (defined as 100% activity) over
pure amylopectin (51.5%), which contains a-1,6 branch points
about every 25 glucose residues. In addition, it is able to process
pullulan (46.8%), a property not universally possessed by
a-amylase enzymes. Interestingly, SusG is also able to degrade
both b-cyclodextrin and a-cyclodextrin, albeit at rates approxi-
mately 8% and 2% of the rate of soluble starch. The ability to
degrade the cyclodextrins was surprising, as these tend to act
as nonhydrolyzable inhibitors for most amylose/amylopectin-
preferring amylases.
The reaction products of WT SusG on maltooligosaccharides,
amylose, amylopectin, pullulan, dextran, cyclodextrins, and
acarbose were analyzed by TLC (Figure S1). All of the substrates
tested were significantly degraded with the exception of
maltose, acarbose, and dextran. Typical byproducts were glu-
cose and maltose for maltose oligosaccharides (G3–G7),208 Structure 18, 200–215, February 10, 2010 ª2010 Elsevier Ltd Alla- and b-cyclodextrin, amylose, and amylopectin. SusG
degraded pullulan exclusively to panose (Glc-a1,6-Glc-a1,
4-Glc), with strict specificity for the a1,4-glycosidic bonds. This
is consistent with the finding that SusG has no detectable activity
toward dextran, an a-1,6-linked polymer of glucose (Figure 9).
In order to understand how CBM58 and the surface-binding
site affect the starch-binding properties of the enzyme, several
mutant versions of SusG were created. A mutant of WT SusG
lacking CBM58, named DCBM58, was created by deleting resi-
dues 210–339 and inserting the five residue loop GSPTG, similar
to that observed in the H. orenii amylase A, a close structural
homolog of SusG that does not have CBM58. A second mutant
of WT SusG, DSURF, was created by mutating the surface
site (W460A/Y469A/D473V) to prevent starch binding on the
a-amylase domain. The DCBM58, DSURF, and WT-SusG en-
zymes were assayed for activity using p-nitrophenyl-maltopen-
taose (PNP-G5) and were found to have nearly identical catalytic
turnover rates. This suggests that neither mutation significantly
perturbs the intrinsic catalytic rate of the a-amylase (Table 2).
The enzymes were then tested for their ability to degrade
soluble starch, amylopectin, and pullulan. Reactions containedrights reserved
Figure 8. Acarbose Bound to the Secondary
Oligosaccharide-Binding Site Adjacent to
the Active Site
(A) Shown here is the omit electron density, con-
toured at 3s, of acarbose bound to the surface
carbohydrate-binding site immediately adjacent
to the active site.
(B) Comparison of acarbose binding (solid sticks)
with that of the SusG-D498N structure cocrystal-
lized with maltoheptaose (transparent model).
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Structure of a Bacteroides a-Amylase, SusGequal amounts (50 nM) of enzyme, and the amount of reducing
sugar liberated was quantified in a DNSA-based assay. For
each substrate, the activity of WT SusG was defined as 100%,
and the DCBM58 and DSURF mutant enzymes were compared
to the wild-type. The enzymes had relatively similar levels of
activity on pullulan, with the DCBM58 mutant being 30%
more active than WT, and the DSURF mutant 20% less active
than WT. From the starch preference assay, pullulan is not the
preferred substrate for SusG, and the absence of the starch-
binding sites do not greatly affect enzymatic activity. The solu-
bility and inherent flexibility of pullulan (Leathers, 2003) may
allow it access to the active site without the help of the starch-
binding sites. More profound effects were observed for both
soluble starch and amylopectin. TheDCBM58mutant had signif-
icantly higher activity, with 162% and 292% that of WT SusG
on soluble starch and amylopectin, respectively. If the purpose
of CBM58 is solely to provide the enzyme accessibility to insol-
uble substrates, then it is not surprising that the removal of the
CBM does not decrease catalytic efficacy. However, it was
unexpected to see such an increase in activity on soluble
starch and amylopectin when CBM58 was removed. Isothermal
titration calorimetry (ITC) with isolated CBM58 indicates a Kd ofTable 1. SusG Activity on Various Oligosaccharide Substrates
Activity of WT SusG (%)
Soluble starch 100 ± 4.2
Amylopectin 52 ± 8.0
Pullulan 47 ± 2.6
b-cyclodextrin 7.8 ± 2.0
a-cyclodextrin 1.8 ± 2.6
Structure 18, 200–215, February 10, 201010 mM for maltoheptaose and b-cyclo-
dextrin, and 72 mM for 63-a-D-gluco-
syl-maltotriose-maltotriose, an oligosac-
charide of pullulan. The DSURF mutant
enzyme displays only a slight decrease
in activity on soluble starch and amylo-
pectin, suggesting that, like CBM58, the
surface site is dispensable for soluble
starch degradation. However, unlike the
DCBM mutant, removal of the surface
site does not increase activity.
Thus far, none of the biochemical anal-
yses have identified an essential role for
the starch-binding domain on soluble
forms of starch. Therefore, the ability ofthese mutants to bind and hydrolyze insoluble cornstarch were
measured (Table 2). Both the DCBM58 and DSURF mutant
enzymes had lower efficacy with cornstarch as a substrate
compared to WT SusG, suggesting that both sites play a role
in processing of an insoluble a-glucan. SusG-D498N,
DCBM58-D498N, and CBM58 were tested for their ability to
bind insoluble cornstarch (Figure 10). The CBM58 domain and
the SusG-D498N mutant displayed similar relative affinities for
insoluble cornstarch. The DCBM58-D498N mutant is very defi-
cient in insoluble starch binding, and a precise Kd could not be
determined. This suggests that SusG binding to substrate is
very much dependent upon the CBM58 domain. The fact that
CBM58 alone had the highest affinity for cornstarch may be
due to more facile interactions between such a small protein
and a large starch molecule compared with the full-length
enzyme.
DISCUSSION
The a-amylase SusG has an atypical bilobed structure, with the
core amylase A, B, and C domains at one end and a starch-
specific CBM at the other end that is formed by a large insertion
in the a-amylase domain. This starch-binding domain represents
a new class of CBMs, nowdesignated CBM58 by theCAZy data-
base (Cantarel et al., 2009). Like other starch-specific CBMs, the
a-glucan-binding platform is composed of two aromatic side
chains that create an arc complementing the natural helical twist
of amylose, with additional hydrogen bonding to theO-2 andO-3
atoms of adjacent glucose residues (Boraston et al., 2006; Ma-
chovic and Janecek, 2006). The position of CBM58 in SusG is
highly irregular for two reasons. First, the domain is not at the
N or C terminus of the protein like most CBMs found in theª2010 Elsevier Ltd All rights reserved 209
Figure 9. Thin-Layer Chromatography of
Starch Hydrolysis Byproducts and Stan-
dards
All reactions contained 5 mg/ml of maltooligosac-
charide or starch polysaccharide, 22 mg/ml SusG,
15–20 mMHEPES (pH 7.0), and 75–100 mMNaCl.
Reaction products were sampled after a 2 hr incu-
bation at 37C. G1–G7, maltooligosaccharides;
ACD, a-cyclodextrin; BCD, b-cyclodextrin; Acarb,
acarbose; AP, amylopectin; Dex, dextran; Amy,
amylose; Pul, pullulan.
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Structure of a Bacteroides a-Amylase, SusGa-amylase family (Machovic and Janecek, 2006; Machovic et al.,
2005). Second, CBM58 of SusG does not make any hydrogen-
bond contacts to any part of the core catalytic domain. Whereas
some GH13 enzymes have an N-terminal CBM that is somewhat
extended from the core of the structure, these are typically
involved in dimerization and contribute to the shape and speci-
ficity of the active site of the neighboring molecule (Fritzsche
et al., 2003; Hondoh et al., 2003; Kamitori et al., 1999; Lee
et al., 2002). The extension of CBM58 away from the rest of the
SusG structure is reminiscent of the multidomain endogluca-
nases (i.e., cellulases) Cel9G of Clostridium cellulolyticum (Man-
delman et al., 2003) and CelE4 of Thermomonospora fusca (Sa-
kon et al., 1997), which display a C-terminal cellulose-binding
CBM3 connected to the catalytic domain via a 15–18 residue
linker. In thesecases, the linkermaintains anextendedconforma-
tion via an extensive hydrogen-bond network between the linker
and the two domains. The CBM3 found in the Cel9G and CelE4
endoglucanases is believed to disrupt the hydrogen-bonding
network of crystalline cellulose and guide the cellulose chains
to the catalytic site, because the flat face of CBM3 is in-line
with the active site on the catalytic domain. With SusG, the
starch-binding site on CBM58 is 45 A˚ away from, and at 90 to,
the active site, making it difficult to envision a similar mechanism.
An overlay of the catalytic domains of the two noncrystallo-
graphically related copies of SusG in the maltoheptaose-bound
D498N structure showed a displacement of the CBM by only
a few A˚ngstroms. The small amount of movement observed
and the relatively short length (12 A˚) of the strands linking
CBM58 to the B domain make it difficult to envision it passing
maltooligosaccharide to the catalytic domain. Perhaps this flex-
ibility is important for interacting with, or channeling substrates
to, other members of the Sus complex.
Generally speaking, CBMs of glycoside hydrolases promote
adsorption to an insoluble substrate, disrupt the structure ofTable 2. Role of Carbohydrate-Binding Regions on Oligosaccharide Processing
vi (min
1), 2 mM PNP-G5 vi (min
1), 0.2 mM PNP-G5 Pullulan (%) Soluble Starch (%)
WT 100 ± 1.3 100 ± 1.6 100 ± 8.1 100 ± 12.7
DCBM 112 ± 0.6 103 ± 1.4 137 ± 7.1 162 ± 5.9
DSURF 102 ± 6.2 90 ± 2.4 79 ± 9.8 82 ± 3.8
210 Structure 18, 200–215, February 10, 2010 ª2010 Elsevier Ltd All rights reservedthe polysaccharide, and improve cata-
lytic efficacy by concentrating the en-
zyme on the glycan (Boraston et al.,
2004). In members of the GH13 family,
mutation of a CBM can dramaticallydecrease the ability of the enzyme to utilize raw or granular
starch (Penninga et al., 1996; Sumitani et al., 2000; Tan et al.,
2008), and the addition of a CBM can enhance the ability to
digest raw starch (Juge et al., 2006; Latorre-Garcia et al.,
2005). CBM58 clearly enhances the ability of SusG to bind insol-
uble cornstarch, because the DCBM-D498N mutant has at least
10-fold weaker binding compared to SusG-D498N (Figure 10).
Residual binding of DCBM-D498N is likely due to binding at
the surface site on the catalytic domain. For optimal degradation
of insoluble cornstarch, both CBM58 and the surface site are
required because the DCBM and DSURF mutants display simi-
larly reduced levels of activity compared to WT SusG. In con-
trast, CBM58 seems to actually hinder degradation of soluble
starch and amylopectin (Table 2). This disparity between soluble
and insoluble starch digestion was surprising. Perhaps the func-
tion of CBM58 in SusG is not simply to concentrate the enzyme
on the substrate, a role typically assigned to CBMs. CBM58may
have an essential starch-binding role that affects the apparent
rate of catalysis yet is not directly related to enzyme activity. In
vivo, CBM58 may help sequester a-glucan substrates or prod-
ucts to the cell surface for passage to other members of the
Sus complex or into the SusC porin. In vitro, tight binding of
CBM58 to starch may aid insoluble starch degradation by
enhancing the local concentration of the substrate but inhibit
the processivity of the reaction on a soluble substrate that can
access the active site without the aid of a CBM.
Many amylases, such as barley a-amylase (Kadziola et al.,
1998; Robert et al., 2005; Sogaard et al., 1993), yeast glucoamy-
lase (Sevcik et al., 2006), salivary amylase (Ragunath et al.,
2008), and pancreatic amylase (Payan and Qian, 2003; Qian
et al., 1995), do not have a starch-binding CBM, but instead
have one ormore secondary starch-binding sites on the catalytic
domain for raw starch utilization. In addition to CBM58, SusG
also has a secondary starch-binding site (the ‘‘surface site’’) onAmylopectin (%) Insoluble Cornstarch (%)
100 ± 8.1 100 ± 5.7
292 ± 9.6 29 ± 1.4
91 ± 3.7 44 ± 2.8
Figure 10. Protein Binding to Insoluble Cornstarch
Fraction of protein bound versus mg of cornstarch was plotted and
fit using the one-site, total binding model (Bmax = 1) in the program
Prism. A Kd was not calculated for the DCBM58-D498N mutant
because the degree of saturation was too low to accurately extrapo-
late.
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Structure of a Bacteroides a-Amylase, SusGthe catalytic domain directly adjacent to the active site (Figure 2).
However, in SusG, the surface-binding site is only 4.5 A˚ to the
active site, whereas these sites in other amylases are typically
separated by distances of 15 A˚ or more. Further, in SusG, the
reducing ends of the bound oligosaccharides are pointed toward
each other, making it unlikely that a single a-glucan chain spans
both sites. Although the presence of the surface site in SusG aids
the hydrolysis of insoluble starch (Table 2), the orientation of the
maltooligosaccharide at the surface site may hint at a distinct
role for this site. At the surface site, the hydrophobic platform
created by W460 and Y469 is more or less perpendicular with
the protein surface, and maltoheptaose binds along the length
of the protein with many additional interactions between the
reducing end of the sugar and the protein. Such an orientation
precludes a longer amylose helix from binding, as the pitch of
the helix would be directed into the protein instead of along the
surface. This is in contrast to barley a-amylase, in which two
tryptophan residues at the raw starch-binding site lie parallel to
the surface of the protein, allowing larger amylose helices to
bind. These differences suggest that perhaps SusG uses this
site to sequester reaction products for subsequent import via
the other Sus proteins.
In summary, it is clear that SusG has complex interactions
with large polysaccharides; however, there is an apparent
disconnect between oligosaccharide binding and in vitro cata-
lytic turnover that may be pointing to the in vivo functions of
these sites. Without the CBM58 domain, SusG binds very
weakly to insoluble starch and, in fact, CBM58 binds better
alone to starch than when linked to the rest of the enzyme. In
contrast, the removal of CBM58 improves catalytic efficiency
using soluble oligosaccharides (up to 3-fold in the case of
amylopectin) with only 55% loss in activity against insoluble
starch. Similarly, the surface starch-binding domain on the
amylase does not seem to play a large role in digestion of
soluble carbohydrates, but seems to be more important in pro-
cessing insoluble starch. However, neither additional carbohy-
drate-binding region appears to be essential for processing
these substrates. It has been previously demonstrated that a
DsusABCDEFG mutant complemented with SusG cannot grow
on amylose or amylopectin (Shipman et al., 1999), yet can
grow on maltose and maltotriose. If SusG acts mainly toStructure 18, 200–215, Fdegrade a-glucan polymers to maltooligosaccharides
as small as maltose, then it is not clear why this comple-
mentation mutant cannot utilize the larger substrates and
import the products via other maltotriose/maltose uptake
systems. It seems probable that the binding modules on
SusG have a far greater role in starch sequestering and
import within the Sus complex than starch degradation
alone. Future experiments examining the binding and
catalytic properties of the Sus proteins in vivo are neededto build a workingmodel as to how the Sus complex functions as
a whole.
EXPERIMENTAL PROCEDURES
Heterologous Protein Expression
The susG gene (residues 24–692) was amplified by PCR from genomic DNA
prepared from B. thetaiotaomicron ATCC 29148 (also known as VPI-5482).
The amplicon was cloned into pET28rTEV, where the thrombin cleavage site
of pET-28a (Novagen) has been modified to a tobacco etch virus (TEV)
protease cleavage site. From this wild-type (WT) susG-pET28rTEV construct,
several mutant versions of susG were created. The construct DCBM-pET28-
rTEV was created by PCR amplification of the DNA encoding residues
24–209 and 336–692. A BamHI restriction site was inserted within a linker
region encoding the amino acid sequence G-S-P-T-G to bridge both parts
of the gene. The two pieces of the susG gene were cut with BamHI and ligated
together, followed by PCR amplification of the ligation product to obtain a
continuous susG gene without the CBM (residues 210–335). The DCBM
mutant gene was cloned into pET28rTEV for expression. Additional site-
directed mutants of SusG included the catalytically inactive mutants SusG-
D498N and DCBM-D498N, as well as DSURF (W460A/Y469A/D473V), in
which the surface starch-binding site was removed. These mutants were
constructed in the corresponding susG-pET28rTEV or DCBM-pET28rTEV
expression plasmid using the QuikChange II Multi Site-Directed Mutagenesis
kit (Stratagene) according to the manufacturer’s instructions. The CBM of
SusG, residues 215–337, was cloned and expressed independently as well,
in a similar manner as described for the SusG enzymes. All primers utilized
for cloning and mutagenesis are listed in Table S1.
Native SusG, mutants of SusG, and CBM58 alone were expressed similarly
with an rTEV-cleavable N-terminal 6-His tag. The pET28rTEV plasmids were
transformed into Rosetta (DE3) pLysS (Novagen) for protein expression. Cells
were grown in TBmedium at 37Cwith shaking (225 rpm) until they reached an
OD of 0.4, at which time the temperature was adjusted to 22C. At an OD
of 0.8, cells were treated with 0.2 mM ITPG to induce protein expression
and allowed to grow 16 hr at 22C. Cells were subsequently harvested by
centrifugation, frozen in liquid nitrogen, and stored at 80C. Selenomethio-
nine-substituted protein was produced via the methionine inhibitory pathway
(Van Duyne et al., 1993) as previously described (Koropatkin et al., 2007).
Purification of Native and Selenomethionine-Substituted SusG
All SusG proteinswere purified using a 5ml Hi-Trapmetal-affinity cartridge (GE
Healthcare) according to the manufacturer’s instructions. The cell lysate was
applied to the column in His buffer (25 mM NaH2PO4, 500 mM NaCl, 20 mM
imidazole [pH 7.4]) and SusG was eluted with an imidazole (20–300 mM)
gradient. The His tag was removed by incubation with rTEV (1:100 molar ratio
relative to protein) at room temperature for 16 hr. The cleaved protein was then
dialyzed against His buffer and the His-tagged rTEV and undigested targetebruary 10, 2010 ª2010 Elsevier Ltd All rights reserved 211
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against 20 mM HEPES, 100 mM NaCl (pH 7.0) prior to crystallization.
Crystallization and Data Collection
All crystals were grown using the hanging-drop vapor-diffusion method, and
Hampton Screen kits (Hampton Research) were used to determine initial
conditions. Large single crystals of selenomethionine-substituted (SeMet)
WT SusG were grown at room temperature using 11 mg/ml of SusG and
mother liquor that contained 18% polyethylene glycol (PEG) 4000, 200 mM
magnesium acetate, and 100 mM HEPES (pH 7.5). The SeMet WT-SusG
apo crystals were of the tetragonal space group P41 with unit cell dimensions
of a = b = 128.038 A˚, c = 129.774 A˚. Crystals were serially transferred to a final
cryoprotectant solution composed of 20% ethylene glycol in the abovemother
liquor, and the crystals were flash-frozen in liquid nitrogen. Crystals of SeMet
WT SusG complexed with acarbose were grown at room temperature using
a mother liquor containing 22% PEG 4000, 50 mM LiSO4, and 100 mMHEPES
(pH 7.5). Prior to crystallization, WT SusG (16 mg/ml) was premixed with
10 mM acarbose, 0.5 mM CaCl2 and stored at 4
C from several days to about
2 weeks prior to mixing 1:1 with mother liquor for crystallization trials at room
temperature. The SeMet WT-SusG/acarbose crystals were also of the space
group P41, with unit cell dimensions of a = b = 127.709 A˚, c = 127.987 A˚. For
data collection, crystals were serially transferred into a final cryoprotectant
containing 24% PEG 4000, 200 mM NaCl, 50 mM LiSO4, 10 mM acarbose,
100 mM HEPES (pH 7.5), and 19% ethylene glycol, and flash-frozen in liquid
nitrogen.
Native SusG-D498N crystals complexed with maltoheptaose were grown at
room temperature using a 9.3 mg/ml protein solution containing 10 mMmalto-
heptaose and 0.5mMCaCl2, and then diluted 1:1 withmother liquor containing
19%–20% PEG 4000, 100 mM LiSO4, and 100 mM HEPES (pH 7.5). For data
collection, crystals were serially transferred into cryoprotectant containing
20% PEG 4000, 50 mM NaCl, 100 mM LiSO4, 10 mM maltoheptaose, and
15% ethylene glycol, and flash-frozen in liquid nitrogen prior to data collection.
Diffraction maxima for all three data sets were collected on a 3 3 3 tiled
SBC3 CCD detector at the Structural Biology Center 19-ID beamline
(Advanced Photon Source, Argonne National Laboratory, Argonne, IL, USA).
X-ray data were processed with HKL3000 and scaled with SCALEPACK (Otwi-
nowski and Minor, 1997). Data collection statistics are reported in Table S2.
X-Ray Structure Determination
The structure of SusG was solved using SAD phasing from the X-ray data
collected from the SeMet WT-SusG apo crystals. The programs SHELXD
and SHELXE (Sheldrick, 2008) were used to determine the initial positions of
the selenomethionines and estimate the initial phases from the peak wave-
length data set, followed by refinement of the heavy-atom parameters using
MLPHARE from the CCP4 suite of programs (CCP4, 1994). Solvent flattening
was performed using DM (Cowtan, 1994; Terwilliger, 2000), and ARP/wARP
(Morris et al., 2003) was used for initial model building. Alternate cycles of
manual model building in O (Jones et al., 1991) with maximum-likelihood
refinement with CNS (Brunger et al., 1998) was then used to build and refine
the 2.2 A˚ selenomethionine-substituted SusG structure. The structures of
SusG complexed with acarbose and maltoheptaose were determined by
molecular replacement using the program AMoRe (Navaza, 1994) from the
CCP4 suite of programs (CCP4, 1994) with the apo WT-SusG structure as
a searchmodel. Alternate cycles of manual model building in O and refinement
using CNS were combined to complete the models, and the geometry was
analyzed using PROCHECK (Laskowski et al., 1993). In all three models,
residue 634 was on the border of the allowed/disallowed region of the Rama-
chandran analysis. Initial coordinates and geometric constraints for the oligo-
saccharides were downloaded from the HIC-Up server (http://xray.bmc.uu.se/
hicup). Relevant refinement statistics are presented in Table S2.
Thin-Layer Chromatography
The reaction byproducts of WT SusG with various starch substrates were
analyzed by thin-layer chromatography. Each reaction contained 22 mg/ml of
SusG in 20 mM HEPES (pH 7.0), 100 mM NaCl and 5 mg/ml of one of the
following: amylose, amylopectin, pullulan, a-cyclodextrin, b-cyclodextrin,
dextran, maltose, maltotriose, maltotetraose, maltopentaose, maltohexaose,
maltoheptaose, or acarbose. After 5 hr at 37C, 3 ml of each reaction was212 Structure 18, 200–215, February 10, 2010 ª2010 Elsevier Ltd Allblotted onto a 20 cm 3 20 cm, 500 mm thick Partisil PK6F silica gel 60 A˚ plate
(Whatman). The spots were dried by incubation in an 80C oven for 5 min, and
then another 3 ml of each reaction was added to the correct spot. The plate was
dried a second time and then transferred to a solvent chamber containing
a 3:1:1 mixture of isopropanol:ethyl acetate:water. Two irrigations were per-
formed, drying the plate between washes. Controls of each sugar (2–5 mg/
ml) were also blotted on the plate for comparison and determination of the
reaction products, as well as isomaltose and panose, two potential products
of dextran and pullulan hydrolysis.
Starch Specificity Assay
The ability of WT SusG to degrade various forms of starch was tested by moni-
toring the reducing sugars released over time using a dinitrosalicylic acid
(DNSA) -based assay (Bernfeld, 1955). Each 1 ml reaction contained 450 ml
of buffer A (20 mM HEPES, 100 mM NaCl [pH 7.0]), 500 ml of 10 mg/ml of pul-
lulan (Sigma P4516), soluble starch (from potato; Sigma S2004), amylopectin
(from maize; Sigma 10120), a-cyclodextrin (Fluka 28705), or b-cyclodextrin
(Sigma C4767) in buffer A, and 50 ml of 0.43 mg/ml WT SusG. Reactions
were performed in triplicate at 37C. The amount of reducing sugar was
assayed at 0 and 10 min by mixing equal amounts of the reaction mixture
with the DNSA reagent (1% DNSA, 0.2% phenol, 1% NaOH, 0.05% sodium
sulfite, 0.004% glucose), followed by heating at 100C for 15 min. Samples
were incubated on ice for 5 min, equilibrated to room temperature, and the
absorbance at 575 nmwasmeasured. The amount of reducing sugar liberated
was determined via a standard curve using maltose, and included the assayed
starch substrate to account for intrinsic maltooligosaccharides. These results
are summarized in Table 1.
SusG Mutant Activity on Various Substrates
The relative activities of WT SusG, DCBM, and DSURF were examined in
a series of assays using equimolar concentrations of the proteins. Protein
concentrations were determined using the Pierce BCA protein assay kit
(Thermo Fisher Scientific) according to the manufacturer’s instructions. The
enzymes were tested for activity on the starch analog p-nitrophenyl-maltopen-
taose (PNP-G5) in a continuous spectrophotometric assay monitoring the
increase in A420nm over time. Each reaction contained 10 mM enzyme, 20 mM
HEPES (pH 7.0), 1.0 mM CaCl2, 100 mM NaCl, and 0.2 or 2.0 mM PNP-M5.
After confirming that the three SusG enzymes had nearly identical initial veloc-
ities with PNP-M5 as a substrate, the enzymes were tested for their ability to
degrade pullulan (Sigma P4516), soluble starch (partially hydrolyzed potato
starch; Sigma S2004), and amylopectin (from maize; Sigma 10120) using the
DNSA-based reducing sugar assay. Soluble starch and amylopectin solutions
were dissolved in buffer A by brief heating, then cooled to room temperature.
Reactions, performed in triplicate, were initiated by the addition of 1.8 ml of
5 mg/ml polysaccharide solution in buffer A to 200 ml of 0.5 mM enzyme. At
0 and 25 min incubation at 22C, three 250 ml aliquots of each reaction were
mixed with 250 ml of DNSA reagent and processed as previously described.
The SusG enzymes were also assayed for their ability to degrade insoluble
cornstarch (Sigma S4126). These reactions contained 2ml of a 50mg/ml slurry
of buffer-washed cornstarch in buffer A. Reactions were initiated by the addi-
tion of 0.5 ml of 25 mM enzyme, and incubated at 37C with vigorous agitation.
At 0, 10, 20, 30, and 40 min, 310 ml of the reaction was removed and centri-
fuged for 1 min to pellet the starch. Two hundred fifty microliters of the super-
natant was added to 250 ml of the DNSA reagent, and the assaywas developed
as previously described.
Insoluble Starch Binding
The SusG-D498N, DCBM-D498N, and CBM58 proteins were assayed for their
ability to adsorb to insoluble cornstarch. Cornstarch was prepared by washing
several times with an excess of double-distilled water, followed by buffer A.
A 100 mg/ml suspension of cornstarch in buffer A was dispensed into 1.5 ml
microfuge tubes for aliquots containing 2, 5, 10, 25, 38, 50, 75, and 100 mg
of cornstarch. The polysaccharide was pelleted by centrifugation and all
supernatant was carefully removed. To each aliquot, 0.45 ml of 1 mg/ml of
SusG-D498N, DCBM-D498, CBM58, or bovine serum albumin (BSA) was
added. The reactions were agitated at 22C for 2 hr, and then centrifuged to
pellet the cornstarch and bound protein. Two 25 ml aliquots of each sample
were removed and the amount of protein was measured using the BCA assay.rights reserved
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recovered from each starch aliquot to correct for any dilution due to the wet
starch. The amount of bound protein as a fraction of the total protein versus
mg of cornstarch is plotted in Figure 6. These data were analyzed with the
program Prism (http://www.graphpad.com) by nonlinear regression analysis
using the total binding equation
Y =
BmaxX
KD +X
+NSX +Background;
where Y is the fraction of protein bound, X is amount of cornstarch, KD is the
dissociation constant, Bmax is the maximum amount of bound protein, NS
is the slope of nonspecific binding (Y/X), and Background is the nonspecific
binding observed in the absence of ligand. Because the maximum amount
of protein could not exceed 100%, Bmax was constrained to 1.0 during curve
fitting.
Isothermal Titration Calorimetry
ITC measurements were carried out using a MicroCal VP-ITC titration calorim-
eter (MicroCal). CBM58 was dialyzed overnight against a solution containing
20 mM HEPES (pH 7.0) and 100 mM NaCl, and oligosaccharide solutions
were prepared using dialysis buffer. Protein (0.57 mM) was placed in the reac-
tion cell and the reference cell was filled with deionized water. After the
temperature was equilibrated to 25C, a first injection was performed using
2 ml, followed by 39 successive 6 ml injections of 5mMmaltoheptaose, b-cyclo-
dextrin, or 63-a-D-glucosyl-maltotriose-maltotriose. The solution was stirred
at 460 rpm while the resulting heat of reaction was measured. Baseline
measurements were made using an identical injection regime in the absence
of protein. The data were analyzed by fitting a one-sitemodel with theMicroCal
Origin software package.
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